Anna H.E. Roukens

1.7k total citations
31 papers, 482 citations indexed

About

Anna H.E. Roukens is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anna H.E. Roukens has authored 31 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 11 papers in Epidemiology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anna H.E. Roukens's work include Mosquito-borne diseases and control (10 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Viral Infections and Outbreaks Research (7 papers). Anna H.E. Roukens is often cited by papers focused on Mosquito-borne diseases and control (10 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Viral Infections and Outbreaks Research (7 papers). Anna H.E. Roukens collaborates with scholars based in Netherlands, British Virgin Islands and United States. Anna H.E. Roukens's co-authors include Leo G. Visser, Jaap T. van Dissel, Ann C.T.M. Vossen, Peter J. Bredenbeek, Adriëtte W. de Visser, Simone A. Joosten, Darius Soonawala, Xiaohong Jiang, Emile F.F. Jonker and L. B. S. Gelinck and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Gut.

In The Last Decade

Anna H.E. Roukens

28 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna H.E. Roukens Netherlands 14 239 201 126 118 52 31 482
Qingrui Huang China 12 246 1.0× 106 0.5× 154 1.2× 93 0.8× 150 2.9× 23 514
L. B. S. Gelinck Netherlands 14 346 1.4× 54 0.3× 406 3.2× 149 1.3× 30 0.6× 24 727
Lisa Stockdale United Kingdom 16 422 1.8× 95 0.5× 249 2.0× 320 2.7× 119 2.3× 35 684
Emile F.F. Jonker Netherlands 9 186 0.8× 153 0.8× 112 0.9× 61 0.5× 22 0.4× 10 324
Charmaine Gittleson Australia 8 254 1.1× 41 0.2× 697 5.5× 230 1.9× 87 1.7× 8 841
Alfons Jiménez Spain 14 155 0.6× 350 1.7× 43 0.3× 160 1.4× 92 1.8× 41 625
Robin Kobbe Germany 16 178 0.7× 419 2.1× 110 0.9× 107 0.9× 37 0.7× 44 759
Laure Juompan United States 10 160 0.7× 299 1.5× 121 1.0× 250 2.1× 145 2.8× 14 615
Nanci A. Salles Brazil 16 242 1.0× 234 1.2× 389 3.1× 69 0.6× 32 0.6× 42 718
Macaya Douoguih Netherlands 15 514 2.2× 81 0.4× 251 2.0× 123 1.0× 75 1.4× 42 707

Countries citing papers authored by Anna H.E. Roukens

Since Specialization
Citations

This map shows the geographic impact of Anna H.E. Roukens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna H.E. Roukens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna H.E. Roukens more than expected).

Fields of papers citing papers by Anna H.E. Roukens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna H.E. Roukens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna H.E. Roukens. The network helps show where Anna H.E. Roukens may publish in the future.

Co-authorship network of co-authors of Anna H.E. Roukens

This figure shows the co-authorship network connecting the top 25 collaborators of Anna H.E. Roukens. A scholar is included among the top collaborators of Anna H.E. Roukens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna H.E. Roukens. Anna H.E. Roukens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Roukens, Anna H.E., et al.. (2024). Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines. Vaccine. 42(25). 126093–126093. 1 indexed citations
3.
Jordans, Carlijn, Natasja van Holten, Annelies Verbon, et al.. (2024). Unmasking Individual and Institutional HIV Stigma in Hospitals: Perspectives of Dutch Healthcare Providers. AIDS and Behavior. 28(9). 3184–3195. 4 indexed citations
4.
Prins, Margaretha, et al.. (2024). Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine: secondary analysis of a randomized trial. Research and Practice in Thrombosis and Haemostasis. 8(3). 102419–102419. 3 indexed citations
5.
Geers, Daryl, Rory D. de Vries, Corine H. GeurtsvanKessel, et al.. (2024). Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands. AIDS. 38(9). 1355–1365. 2 indexed citations
6.
Prins, Margaretha, Corine Prins, Jutte J.C. de Vries, Leo G. Visser, & Anna H.E. Roukens. (2023). Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers. Virus Research. 334. 199175–199175. 10 indexed citations
7.
Joosten, Simone A., et al.. (2023). Daily disease severity in patients with COVID-19 admitted to the hospital: The SCODA (severity of coronavirus disease assessment) score. PLoS ONE. 18(9). e0291212–e0291212. 2 indexed citations
8.
Prins, Margaretha, Rob van Binnendijk, Gerco den Hartog, et al.. (2022). Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study. Annals of Internal Medicine. 175(12). 1771–1774. 15 indexed citations
9.
Becchetti, Chiara, Géraldine Dahlqvist, Montserrat Fraga, et al.. (2022). Humoral response to SARS-CoV-2 infection among liver transplant recipients. Gut. 71(4). 746–756. 10 indexed citations
10.
Pongrácz, Tamás, Jan Nouta, Federica Linty, et al.. (2022). Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19. EBioMedicine. 78. 103957–103957. 32 indexed citations
11.
Hoebe, Christian J. P. A., Ann C.T.M. Vossen, Leo G. Visser, et al.. (2019). Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial. The Lancet Infectious Diseases. 20(1). 92–101. 17 indexed citations
12.
Roukens, Anna H.E., Darius Soonawala, Simone A. Joosten, et al.. (2011). Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study. PLoS ONE. 6(12). e27753–e27753. 68 indexed citations
13.
Roukens, Anna H.E., L. B. S. Gelinck, & Leo G. Visser. (2011). Intradermal Vaccination to Protect Against Yellow Fever and Influenza. Current topics in microbiology and immunology. 351. 159–179. 18 indexed citations
14.
Roukens, Anna H.E. & Leo G. Visser. (2011). Hepatitis B vaccination strategy in vaccine low and non-responders: A matter of quantity of quality?. Human Vaccines. 7(6). 654–657. 17 indexed citations
15.
Roukens, Anna H.E., Ann C.T.M. Vossen, Greet J. Boland, et al.. (2010). Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara®). Vaccine. 28(26). 4288–4293. 16 indexed citations
16.
Roukens, Anna H.E., Ann C.T.M. Vossen, Jaap T. van Dissel, & Leo G. Visser. (2009). Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy. Vaccine. 27(18). 2408–2409. 22 indexed citations
17.
Roukens, Anna H.E., Ann C.T.M. Vossen, Peter J. Bredenbeek, Jaap T. van Dissel, & Leo G. Visser. (2008). Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial. PLoS ONE. 3(4). e1993–e1993. 67 indexed citations
18.
Roukens, Anna H.E. & Leo G. Visser. (2008). Yellow fever vaccine: past, present and future. Expert Opinion on Biological Therapy. 8(11). 1787–1795. 36 indexed citations
19.
Roukens, Anna H.E., Ann C.T.M. Vossen, Jaap T. van Dissel, & Leo G. Visser. (2008). Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults. Vaccine. 26(27-28). 3438–3442. 10 indexed citations
20.
Subklewe, Marion, Andrea Block, Anna H.E. Roukens, et al.. (2005). Dendritic Cells Expand Epstein Barr Virus Specific CD8+ T Cell Responses More Efficiently Than EBV Transformed B Cells. Human Immunology. 66(9). 938–949. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingrui Huang Breakdown of academic impact, for papers by L. B. S. Gelinck Breakdown of academic impact, for papers by Lisa Stockdale Breakdown of academic impact, for papers by Emile F.F. Jonker Breakdown of academic impact, for papers by Charmaine Gittleson Breakdown of academic impact, for papers by Alfons Jiménez Breakdown of academic impact, for papers by Robin Kobbe Breakdown of academic impact, for papers by Laure Juompan Breakdown of academic impact, for papers by Nanci A. Salles Breakdown of academic impact, for papers by Macaya Douoguih
Rankless by CCL
2026